Literature DB >> 16540636

Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype.

Nuri Gueven1, Olivier J Becherel, Geoff Birrell, Philip Chen, Giannino DelSal, James P Carney, Padraic Grattan-Smith, Martin F Lavin.   

Abstract

Ataxia-telangiectasia mutated (ATM), the protein defective in ataxia-telangiectasia, plays a central role in DNA damage response and signaling to cell cycle checkpoints. We describe here a cell line from a patient with an ataxia-telangiectasia-like clinical phenotype defective in the p53 response to radiation but with normal ATM activation and efficient downstream phosphorylation of other ATM substrates. No mutations were detected in ATM cDNA. A normal level of interaction between p53 and peptidyl-prolyl-isomerase Pin1 suggests that posttranslational modification was intact in these cells but operating at reduced level. Defective p53 stabilization was accompanied by defective induction of p53 effector genes and failure to induce apoptosis in response to DNA-damaging agents. Continued association between p53 and murine double minute-2 (Mdm2) occurred in irradiated ATL2ABR cells in response to DNA damage, and incubation with Mdm2 antagonists, nutlins, increased the stabilization of p53 and its transcriptional activity but failed to induce apoptosis. These results suggest that ATM-dependent stabilization of p53 and induction of apoptosis by radiation involve an additional factor(s) that is defective in ATL2ABR cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16540636     DOI: 10.1158/0008-5472.CAN-05-3428

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Regulating apoptosis in mammalian cell cultures.

Authors:  Nilou Arden; M J Betenbaugh
Journal:  Cytotechnology       Date:  2006-07-01       Impact factor: 2.058

2.  In vitro characterization of cells derived from chordoma cell line U-CH1 following treatment with X-rays, heavy ions and chemotherapeutic drugs.

Authors:  Takamitsu A Kato; Akihisa Tsuda; Mitsuru Uesaka; Akira Fujimori; Tadashi Kamada; Hirohiko Tsujii; Ryuichi Okayasu
Journal:  Radiat Oncol       Date:  2011-09-14       Impact factor: 3.481

Review 3.  miRNA in spinal muscular atrophy pathogenesis and therapy.

Authors:  Francesca Magri; Fiammetta Vanoli; Stefania Corti
Journal:  J Cell Mol Med       Date:  2017-11-21       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.